246 related articles for article (PubMed ID: 19015318)
1. RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells.
Ordóñez-Morán P; Larriba MJ; Pálmer HG; Valero RA; Barbáchano A; Duñach M; de Herreros AG; Villalobos C; Berciano MT; Lafarga M; Muñoz A
J Cell Biol; 2008 Nov; 183(4):697-710. PubMed ID: 19015318
[TBL] [Abstract][Full Text] [Related]
2. The effects of 1,25-dihydroxyvitamin D3 on colon cancer cells depend on RhoA-ROCK-p38MAPK-MSK signaling.
Ordóñez-Morán P; Alvarez-Díaz S; Valle N; Larriba MJ; Bonilla F; Muñoz A
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):355-61. PubMed ID: 20223287
[TBL] [Abstract][Full Text] [Related]
3. Effects of MAPK signaling on 1,25-dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2.
Cui M; Zhao Y; Hance KW; Shao A; Wood RJ; Fleet JC
J Cell Physiol; 2009 Apr; 219(1):132-42. PubMed ID: 19097033
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer.
Larriba MJ; Ordóñez-Morán P; Chicote I; Martín-Fernández G; Puig I; Muñoz A; Pálmer HG
PLoS One; 2011; 6(8):e23524. PubMed ID: 21858154
[TBL] [Abstract][Full Text] [Related]
5. Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer.
Larriba MJ; Martín-Villar E; García JM; Pereira F; Peña C; de Herreros AG; Bonilla F; Muñoz A
Carcinogenesis; 2009 Aug; 30(8):1459-68. PubMed ID: 19502595
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of Wnt/beta-catenin signalling by 1alpha,25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells.
Larriba MJ; Valle N; Pálmer HG; Ordóñez-Morán P; Alvarez-Díaz S; Becker KF; Gamallo C; de Herreros AG; González-Sancho JM; Muñoz A
Endocr Relat Cancer; 2007 Mar; 14(1):141-51. PubMed ID: 17395983
[TBL] [Abstract][Full Text] [Related]
7. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
[TBL] [Abstract][Full Text] [Related]
8. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
10. Interference with RhoA-ROCK signaling mechanism in autoreactive CD4+ T cells enhances the bioavailability of 1,25-dihydroxyvitamin D3 in experimental autoimmune encephalomyelitis.
Paintlia AS; Paintlia MK; Hollis BW; Singh AK; Singh I
Am J Pathol; 2012 Sep; 181(3):993-1006. PubMed ID: 22796435
[TBL] [Abstract][Full Text] [Related]
11. Phorbol esters enhance 1α,25-dihydroxyvitamin D3-regulated 25-hydroxyvitamin D-24-hydroxylase (CYP24A1) gene expression through ERK-mediated phosphorylation of specific protein 3 (Sp3) in Caco-2 cells.
Jiang Y; Fleet JC
Mol Cell Endocrinol; 2012 Sep; 361(1-2):31-9. PubMed ID: 22871965
[TBL] [Abstract][Full Text] [Related]
12. The effect of 1,25 dihydroxyvitamin D3 treatment on the mRNA levels of β catenin target genes in mice with colonic inactivation of both APC alleles.
DeWitt M; Johnson RL; Snyder P; Fleet JC
J Steroid Biochem Mol Biol; 2015 Apr; 148():103-10. PubMed ID: 25597951
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
[TBL] [Abstract][Full Text] [Related]
14. A novel RhoA/ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression.
Pagiatakis C; Gordon JW; Ehyai S; McDermott JC
J Biol Chem; 2012 Mar; 287(11):8361-70. PubMed ID: 22275376
[TBL] [Abstract][Full Text] [Related]
15. Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation.
Toque HA; Nunes KP; Yao L; Liao JK; Webb RC; Caldwell RB; Caldwell RW
J Sex Med; 2013 Jun; 10(6):1502-15. PubMed ID: 23566117
[TBL] [Abstract][Full Text] [Related]
16. 1α,25-Dihydroxyvitamin D
Ishizawa M; Akagi D; Yamamoto J; Makishima M
J Steroid Biochem Mol Biol; 2017 Sep; 172():55-61. PubMed ID: 28578001
[TBL] [Abstract][Full Text] [Related]
17. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
18. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L
Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880
[TBL] [Abstract][Full Text] [Related]
19. The 3-epi- and 24-oxo-derivatives of 1alpha,25 dihydroxyvitamin D(3) stimulate transcription through the vitamin D receptor.
Messerlian S; Gao X; St-Arnaud R
J Steroid Biochem Mol Biol; 2000; 72(1-2):29-34. PubMed ID: 10731635
[TBL] [Abstract][Full Text] [Related]
20. Regulation of CYP24 splicing by 1,25-dihydroxyvitamin D₃ in human colon cancer cells.
Peng X; Tiwari N; Roy S; Yuan L; Murillo G; Mehta RR; Benya RV; Mehta RG
J Endocrinol; 2012 Feb; 212(2):207-15. PubMed ID: 22068926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
